Forde PM, Anagnostou V, Sun Z, Dahlberg SE, et al. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial. Nat Med 2021;27:1910-1920.
PMID: 34750557